Atlas Trials

Treatment of Cerebral Arteriovenous Malformations With SQUID Liquid Embolic Agent (CHOICE)

Clinical trial NCT03413852 · UNKNOWN

Trial details

NCT number
NCT03413852
Sponsor
Embo-Flüssigkeiten A.G.
Status
UNKNOWN
Study type
OBSERVATIONAL
Cerebral Arteriovenous Malformation
Start date
2018-05-11
Primary completion
2022-03-01
Enrollment
111

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.